Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Wein

Showing results (1-10 of 417) with videos related to

Pageof 42
Sort By:
The Urologic Clinics of North America|May 1, 1987
Lower urinary tract function and pharmacologic management of lower urinary tract dysfunctionA J Wein
The American Journal of Managed Care|February 24, 2001
Overactive bladder: defining the diseaseA J Wein
Expert Opinion on Investigational Drugs|December 16, 2000
Pharmacological agents for the treatment of urinary incontinence due to overactive bladderA J Wein
The Urologic Clinics of North America|August 1, 1995
Pharmacology of incontinenceA J Wein
Advances in Experimental Medicine and Biology|January 1, 1995
Bladder outlet obstruction--an overviewA J Wein
BJU International|June 8, 2004
A randomized crossover study to evaluate RO 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinenceA J Wein
The Urologic Clinics of North America|May 1, 1991
Practical uropharmacologyA J Wein
The Journal of Urology|September 1, 1997
Nitric oxide and interstitial cystitisA J Wein
The Journal of Urology|May 23, 1998
Studies of the KATP channel opening activity of the new dihydropyridine compound 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H, 5H)-acridinedione in bladder detrusor in vitroA J Wein
The Journal of Urology|August 1, 1981
Urodynamics: promises, promises, promisesA J Wein
Pageof 42

Showing results (1-10 of 417) with videos related to

Sort By:
Pageof 42
The Urologic Clinics of North America|May 1, 1987
Lower urinary tract function and pharmacologic management of lower urinary tract dysfunctionA J Wein
The American Journal of Managed Care|February 24, 2001
Overactive bladder: defining the diseaseA J Wein
Expert Opinion on Investigational Drugs|December 16, 2000
Pharmacological agents for the treatment of urinary incontinence due to overactive bladderA J Wein
The Urologic Clinics of North America|August 1, 1995
Pharmacology of incontinenceA J Wein
Advances in Experimental Medicine and Biology|January 1, 1995
Bladder outlet obstruction--an overviewA J Wein
BJU International|June 8, 2004
A randomized crossover study to evaluate RO 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinenceA J Wein
The Urologic Clinics of North America|May 1, 1991
Practical uropharmacologyA J Wein
The Journal of Urology|September 1, 1997
Nitric oxide and interstitial cystitisA J Wein
The Journal of Urology|May 23, 1998
Studies of the KATP channel opening activity of the new dihydropyridine compound 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H, 5H)-acridinedione in bladder detrusor in vitroA J Wein
The Journal of Urology|August 1, 1981
Urodynamics: promises, promises, promisesA J Wein
Pageof 42